/images/topic.png)
Category Archives: Main
FDA Strengthens Warnings on Gadolinium MRI Dyes
Gadolinium-based contrast dyes will now bear new warnings on their labels regarding their association with nephrogenic systemic fibrosis (NSF), according to the Food & Drug Administration (FDA). Gadolinium-based contrast dyes are intravenous drugs approved by the FDA for use with …
Restrict Omniscan, OptiMark, FDA Panel Says
A panel convened by the Food & Drug Administration (FDA) has found that Omniscan, OptiMark and Magnevist appear to carry the greatest risk of nephrogenic systemic fibrosis. The group of outside experts recommended that the labeling for OptiMark and Omniscan …
/images/contact-banner.jpg)